biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > British Columbia Securities Commission!!

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Feb 06, 2023 4:53am

227 Views

Post# 35268548

RE:RE:British Columbia Securities Commission!!

,Step one here is to ensure the IP remains with BTI. We will explore financing options along with advisement from council at every corner to pay off the Lind group, securing our path forward. Initial discussions are taking place already. We have all agreed to start the wheels in motion this week. Not all activity will be discussed in open form on this site of course. Any luck we will encounter will be due to intelligent leg work from here on in!!!

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale